8-KLeadership Changes

APPLIED MATERIALS INC /DE 8-K Report, Executive Changes (Nov 5, 2015)

Filed November 5, 2015For Securities:AMAT

Summary

This 8-K filing by Applied Materials, Inc. (AMAT) announced a significant addition to its Board of Directors. Effective November 4, 2015, Eric Chen was appointed to the Board and also as a member of the Strategy Committee. This move brings new expertise to the company's strategic decision-making processes, which could be particularly relevant given the dynamic nature of the semiconductor equipment industry. Dr. Chen's appointment includes standard compensation for non-employee directors, comprising an annual retainer, meeting fees, and a restricted stock unit grant valued at $200,000. The stock units are set to vest in full on March 1, 2016, contingent upon his continued service. Investors should note that board composition changes can signal shifts in governance or strategic focus, and Dr. Chen's background and experience will be important to monitor for their impact on AMAT's future direction.

Key Highlights

  • 1Appointment of Eric Chen to the Board of Directors, effective November 4, 2015.
  • 2Eric Chen also appointed as a member of the Board's Strategy Committee.
  • 3Dr. Chen will receive standard compensation for non-employee directors.
  • 4Compensation includes an annual retainer and meeting fees.
  • 5A restricted stock unit grant valued at $200,000 will be awarded to Dr. Chen.
  • 6The restricted stock units are scheduled to vest in full on March 1, 2016, subject to continued service.

Frequently Asked Questions

The filing does not provide specific details about Eric Chen's background or professional experience. However, his appointment to the Board and the Strategy Committee suggests he brings relevant expertise to Applied Materials, likely in areas pertinent to the company's strategic direction within the semiconductor industry.

The addition of a new director, especially to a key committee like Strategy, can signal a fresh perspective or a renewed focus on specific strategic initiatives. Investors may want to research Dr. Chen's prior experience and affiliations to infer potential impacts on the company's future plans and decision-making.

Dr. Chen will receive compensation consistent with other non-employee directors. This includes an annual retainer of $65,000 (prorated), $2,000 for each committee meeting attended, and a restricted stock unit grant equivalent to $200,000 worth of Applied Materials' stock, prorated based on service duration, vesting fully on March 1, 2016.

Restricted stock units are a form of equity compensation. They represent a promise to grant shares of the company's stock at a future date, typically after a vesting period. RSUs are often used to incentivize executives and directors to remain with the company and align their interests with shareholders, as the value of the RSUs increases with the company's stock price.